The Middle East and Africa Closed System Transfer Devices Market is set for significant expansion. Expected to grow at a compound annual growth rate (CAGR) of 15.8% from 2021 to 2028, the market is projected to reach USD 48,138.62 thousand by 2028. This article explores market dynamics, segmentation, drivers, challenges, and competitive insights, drawing exclusively from Data Bridge Market Research to provide strategic guidance for stakeholders.
What Are Closed System Transfer Devices?
Closed system transfer devices are specialized drug transfer systems that maintain sterility during compounding and administration, protecting healthcare workers from exposure to hazardous agents like chemotherapy drugs. Compliant with standards such as USP <800> and NIOSH, CSTDs incorporate technologies like diaphragm-based mechanisms to eliminate needlestick risks and aerosol emissions, making them vital in oncology and pharmacy settings.
Market Size and Growth Projections
The MEA CSTD market demonstrates strong growth potential, driven by increasing oncology treatments and safety mandates. From historical data spanning 2010-2019, the market is forecasted to expand robustly through 2028, with projections in USD thousand reflecting revenue from devices and accessories.
| Year/Period | Market Value (USD Thousand) | CAGR (%) |
|---|---|---|
| Historical (2010-2019) | Base data available | - |
| Forecast (2021-2028) | Projected to 48,138.62 by 2028 | 15.8 |
| 2019 (Reference) | Customizable data available | - |
Download Full Report : https://www.databridgemarketresearch.com/reports/middle-east-and-africa-closed-system-transfer-devices-market
Market Segmentation
The market is segmented across multiple dimensions to identify high-potential areas:
By Type
- Membrane-to-Membrane Systems: Dominated in 2021 for superior contamination resistance and compatibility with existing equipment.
- Needle-Free Closed System Transfer Device: Growing for enhanced safety in needle-phobic environments.
By Component
- Devices: Largest share in 2021 due to higher pricing and core functionality; includes vial access devices, syringe safety devices, bag/line access devices, and vented bag spikes.
- Accessories: Supports devices with items like assembly fixtures, connectors, catheter adapters, and infusion clamps.
By Closing Mechanism
- Click-to-Lock Systems: Held the majority share in 2021 for simplicity and effective contamination protection.
- Push-to-Turn Systems: Gaining traction for user-friendly designs.
- Color-to-Color Alignment Systems: Preferred for visual alignment ease.
- Luer-Lock System: Standard for secure connections.
By Technology
- Diaphragm-Based Devices: Dominant in 2021 for reliability and provider preference.
- Compartmentalized Devices: Emerging for isolated handling.
- Air Cleaning/Filtration Devices: Focused on vapor control.
By End User
- Hospitals: Led in 2021, driven by regulatory requirements for hazardous drug handling.
- Oncology Centers & Clinics: Rapid growth amid cancer case surges.
- Ambulatory Surgical Centers: Increasing for outpatient procedures.
- Academic and Research Institutes: Key for R&D applications.
By Distribution Channel
- Retail Sales: Dominated in 2021, reliant on local distributors with international partnerships.
- Direct Tender: Growing through government procurement in public health systems.
By Country
- South Africa: Market leader with robust imports and infrastructure.
- Saudi Arabia: Boosted by Vision 2030 healthcare investments.
- U.A.E.: Urban expansion drives demand.
- Egypt, Israel, and Rest of MEA: Steady growth via emerging oncology facilities.
Key Drivers Fueling Growth
- Rising Safety Concerns for Healthcare Workers: Increased awareness of exposure risks to hazardous drugs accelerates CSTD adoption.
- Technological Advancements: Innovations in effective drug delivery systems enhance compliance and efficiency.
- Growing Cancer Prevalence: Higher incidence rates in MEA necessitate more oncology treatments and safe handling tools.
- Increasing Oncology Drug Approvals: Regulatory nods for new therapies expand the need for compatible CSTDs.
Challenges and Restraints
- Shortage of Skilled Personnel: Limited training in handling advanced devices hampers implementation.
- Compatibility Issues: Challenges between biologics and CSTD materials affect performance.
- High Costs: Elevated pricing of CSTDs strains budgets in resource-limited settings.
- Stringent Regulations: Evolving standards for drug handling devices increase compliance burdens.
- COVID-19 Supply Chain Disruptions: Pandemic-related raw material shortages impacted production and availability.
Opportunities
- Government Research Funding: Investments in safe drug handling promote CSTD development.
- Promotional Efforts for Cancer Research: Initiatives by organizations drive awareness and adoption.
- Strategic Partnerships and Mergers: Collaborations expand market reach and innovation.
- Pharmacy Availability Growth: Wider distribution channels enhance accessibility.
Competitive Landscape
The market is competitive, featuring global leaders and regional players emphasizing acquisitions and agreements for expansion:
- ICU Medical, Inc.
- BD
- B. Braun Medical Inc.
- EQUASHIELD
- Simplivia
- Vygon
- Epic Medical
Key strategies include long-term contracts and mergers. For instance, Simplivia's January 2021 acquisition of 70% stake in Novamed bolstered its homecare and pharmaceutical presence, while ICU Medical's April 2019 agreement with Scripps Health secured supply of IV solutions and software.
Future Trends and Opportunities
By 2028, the market will shift toward diaphragm-based, needle-free technologies with integrated filtration for superior safety. Regional focus on South Africa and Saudi Arabia will intensify with oncology infrastructure builds, while opportunities in ambulatory centers and research institutes arise from funding surges. Expect more mergers to address compatibility challenges and cost barriers.
Conclusion
The Middle East and Africa Closed System Transfer Devices Market is poised for dynamic growth to USD 48,138.62 thousand by 2028 at 15.8% CAGR, propelled by oncology demands and safety imperatives. Stakeholders should leverage partnerships and innovations to navigate restraints like costs and skills gaps. Prioritizing compliance with global standards will unlock opportunities in this high-potential region.
Browse More Reports:
Global Video Laryngoscope Market
France Flow Cytometry Market
Global Mobile Payment Technologies Market
Global Carbon Fiber Market
Global Gluten-free Vegan Snacks Market
Global Flow Cytometry Market
Global Men’s Skincare Products Market
Global Micro Data Center Market
Global Tennis Racquet Market
Global Agricultural Nanotechnology Market
Global Natural Food Colors Market
Global Barium Market
Global Center Pivot Irrigation Systems Market
Global Autonomous Underwater Vehicle (AUV) Market
Global Closed System Transfer Devices Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience, which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com
